578 filings
Page 5 of 29
S-3ASR
pvgoz45lmcbr tz
9 Oct 15
Automatic shelf registration
12:00am
8-K
eatd8h080njk38s
5 Oct 15
Strengthens core position in treatment of rare diseases and provides additional opportunities for growth
12:00am
8-K
xy1sixcriqeiozal3fd
14 Sep 15
Raptor Pharmaceutical Provides Topline Results from Phase 2b CyNCh Study Evaluating RP103 in Pediatric Nonalcoholic Steatohepatitis
12:00am
8-K
jk6b1gcd640d
9 Sep 15
Other Events
12:00am
8-K
dc34of70do uirxcw24a
8 Sep 15
Entry into a Material Definitive Agreement
12:00am
8-K
za9ale
8 Sep 15
Entry into a Material Definitive Agreement
12:00am
424B5
l0ju62n mkz36i9
8 Sep 15
Prospectus supplement for primary offering
12:00am
8-K
2022272
21 Aug 15
Entry into a Material Definitive Agreement
12:00am
8-K
rkioghws xn43c
6 Aug 15
Raptor Pharmaceutical Corp. Reports Second Quarter 2015 Financial Results and Provides Corporate Update
12:00am
UPLOAD
v4c7ey
30 Jul 15
Letter from SEC
12:00am
CORRESP
55sp5331
22 Jul 15
Correspondence with SEC
12:00am
8-K
3hfs7ngbtrhl gi5
17 Jul 15
Departure of Directors or Certain Officers
12:00am
UPLOAD
zvcd8dc gz
9 Jul 15
Letter from SEC
12:00am
S-8
honxqn4l9na7h v68l
9 Jun 15
Registration of securities for employees
12:00am
8-K
k0c 6io5gez
20 May 15
Departure of Directors or Certain Officers
12:00am
8-K
pz578mcbu7qh adgy0
18 May 15
Amendments to Articles of Incorporation or Bylaws
12:00am
DEFA14A
kcqqv00yc90 4h06a
18 May 15
Additional proxy soliciting materials
12:00am